 |
 |
Phil, The real issue is how did it happen that PD research got so under funded and to make sure it doesn't happen again to us or another "disease group". My worry is what power to change things will this group have. Will it be merely a group to be used to pacify the stir in congress about i.e. earmarking etc. or will it be listened to in some meaningful way. Charlie Phil Tompkins wrote: > This is, as it says, certainly not a position from which to advocate > for PD, and for anyone with that as a driving concern there are lots > of other things that need doing. It's instead for general advocacy > benefiting a broader public, and it may mean advocating for the NIH > in the other direction as well. > > Charlie, it's great to see your enthusiasm for this, especially > since you are qualified in so many ways. Your message about taking a > broader perspective looks like a start on your letter of nomination. > I'm real glad. > > Phil Tompkins > Hoboken NJ > age 60/dx 1990 -- ****************************************************************************************** Charles T. Meyer, M.D. Middleton (Madison), Wisconsin [log in to unmask] ******************************************************************************************